台股 » 個股 » 智擎 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智擎

(4162)
可現股當沖
  • 股價
    100.5
  • 漲跌
    ▼3.0
  • 漲幅
    -2.90%
  • 成交量
    1,644
  • 產業
    上櫃 生技醫療類股
  • 309人加入追蹤

    立即追蹤

  • 本地時間:14:30(已收盤)

     
智擎 (4162)籌碼相關-元富-世貿 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw03/0803/1803/2804/2005/0405/1806/0106/1406/2807/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1412/2801/1002/0202/1202/249095100105110115120125May '24Jul '24Sep '24Nov '24Mar '2560d90dAll

元富-世貿 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/03/2810103.0000.00100.50101,7520.57%
2025/03/2610105.0000.00104.50101,7230.58%
2025/03/2510105.0000.00104.50101,7190.58%
2025/03/2100.001106.50106.50-11,714-0.06%
2025/03/191107.0000.00104.5011,7180.06%
2025/03/1700.001106.50105.00-11,714-0.06%
2025/03/141104.0000.00105.0011,7130.06%
2025/03/130106.0000.00103.5001,7070.00%
2025/03/1200.001107.50107.00-11,695-0.06%
2025/03/111105.5000.00107.0011,6970.06%
2025/03/0600.001115.00111.00-11,647-0.06%
2025/03/0400.005112.00114.50-51,634-0.31%
2025/03/031114.001113.00112.5001,6200.00%
2025/02/2700.002109.50109.00-21,568-0.13%
2025/02/263118.005115.00115.50-21,553-0.13%
2025/02/211113.001112.50113.0001,4120.00%
2025/02/2000.002110.25110.00-21,389-0.14%
2025/02/1800.004109.50110.00-41,401-0.29%
2025/02/1700.002112.50112.50-21,397-0.14%
2025/02/142110.5000.00111.5021,4080.14%
2025/02/121113.502111.00112.00-11,408-0.07%
2025/02/111110.000.1109.00109.000.91,3920.06%
2025/02/0616120.8810120.05119.0061,3290.45%
2025/02/0500.001113.00113.00-11,194-0.08%
2025/02/0400.000.1101.00103.00-0.11,2010.00%
2025/01/090.195.0000.0094.600.11,3410.00%
2025/01/0600.000.1101.00101.50-0.11,259-0.01%
2025/01/03198.30196.6098.3001,2400.00%
2024/12/25391.0000.0091.0031,2140.25%
2024/12/0300.00194.4094.40-11,161-0.09%
2024/11/250.195.4000.0093.800.11,0790.01%
2024/11/20697.53696.5396.5001,0180.00%
2024/11/150.1100.001102.5099.90-0.9989-0.09%
2024/11/1400.001101.50101.50-1971-0.10%
2024/11/131106.0000.00106.5019460.11%
2024/11/072103.502103.00103.5008520.00%
2024/11/0600.004107.25102.50-4826-0.48%
2024/11/056106.422106.50106.0047820.51%
2024/11/0400.003105.33100.00-3758-0.40%
2024/11/014104.7500.00105.0047300.55%
2024/10/306102.506102.00102.0006170.00%
2024/10/2814100.9914102.14102.0005760.00%
2024/10/23292.05294.2093.7004240.00%
2024/10/08193.70191.4091.1005070.00%
2024/09/24088.20288.5090.20-2612-0.33%
2024/09/0200.00186.9086.60-1719-0.14%
2024/08/3000.00186.9087.60-1726-0.14%
2024/08/28186.2000.0086.6017290.14%
2024/08/2600.00187.2086.70-1738-0.14%
2024/08/2100.00186.7086.60-1746-0.13%
2024/08/19184.5000.0084.5017390.14%
2024/08/1600.00084.6084.6007430.00%
2024/08/13185.0000.0084.4017720.13%
2024/08/0700.00487.1086.70-4794-0.50%
2024/08/0600.00180.2080.80-1783-0.13%
2024/08/0500.00192.0083.00-1764-0.13%
2024/07/22192.9000.0092.0017180.14%
2024/07/1900.00194.2094.20-1708-0.14%
2024/07/18198.90299.0599.40-1676-0.15%
2024/07/17198.1000.0098.2016580.15%
2024/07/15197.50199.0098.4006630.00%
2024/07/08399.90499.78100.50-1655-0.15%
2024/07/03196.8000.0096.7016280.16%
2024/06/27398.0700.0095.7035820.51%
2024/06/26298.00197.8097.6015760.17%
2024/06/19194.1000.0093.8016370.16%
2024/06/1700.00195.8095.50-1644-0.16%
2024/06/1400.00195.6095.30-1655-0.15%
2024/06/1100.001293.7095.40-12636-1.88%
2024/05/30190.7000.0090.3017370.14%
2024/05/24192.9000.0092.8018080.12%
2024/05/23293.7000.0093.6028420.24%
2024/05/16195.401296.1595.10-11869-1.26%
2024/05/15494.3300.0093.9049520.42%
2024/05/141295.45296.7094.30101,0430.96%
2024/05/10192.8000.0093.3011,0520.10%
2024/05/09193.8000.0093.3011,0720.09%
2024/05/07192.7000.0092.8011,1160.09%
2024/05/0300.00193.9093.80-11,364-0.07%
2024/04/30194.3000.0093.7011,4250.07%
2024/04/24190.6000.0090.7011,4550.07%
2024/04/2300.00889.8090.20-81,498-0.53%
2024/04/19889.0500.0089.0081,5230.53%
2024/04/11198.4000.0097.9011,6150.06%
2024/04/0900.00198.0097.60-11,722-0.06%
〈焦點股〉智擎胰腺癌新藥展望正向 股價帶量衝高Anue鉅亨-26天前
智擎胰腺癌新藥2024淨銷售額達標 5000萬美元授權金將入袋Anue鉅亨-2025/02/05
智擎 相關文章